Dr. Aleksander Lech Chojecki, MD

Dr. Chojecki practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Chojecki's NPI, 1780997585, was assigned on July 21, 2010. Dr. Chojecki holds North Carolina license 2016-01066.

Dr. Chojecki's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Chojecki's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Chojecki is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Levine Cancer Institute. Dmand AI also links Dr. Chojecki to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chojecki practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chojecki's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Chojecki is licensed in North Carolina.

CMS data shows 256 Medicare services from Dr. Chojecki across 2 procedure codes in 2024, all of them office visits, for 70 Medicare patients. Medicare paid $22,705 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 70 Medicare patients who saw Dr. Chojecki in 2024. The largest group is 75 to 84, with 32 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chojecki's median patient age at 74, with 47% women.

In 2024, Dr. Chojecki wrote 514 Medicare Part D claims for 62 patients. 53% of them were for generic drugs. CMS names the drug for 348 of them, across 17 drugs with 11 or more claims each, at $2,805,723 in total drug cost. In 2023, CMS named 373 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chojecki for performance year 2024, reported as part of a group. Dr. Chojecki accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chojecki as offering telehealth.

Dmand AI links 16 papers to Dr. Chojecki, published from 2018 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Hematopoietic Stem Cell Transplantation, Hematologic Neoplasms and Leukemia, Myeloid, Acute. Dr. Chojecki has published most often in Acta Haematol. Dr. Chojecki's most frequent co-authors are Jing Ai, MD, Michael Richard Grunwald, MD and Thomas Gregory Knight, MD.

CMS Open Payments shows 34 general payments to Dr. Chojecki from 11 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 78% of the total. Servier Pharmaceuticals LLC paid the most, $5,528.